Ding H - Search Results

1

Endothelial dysfunction in diabetes: multiple targets for treatment.

Ding H, Triggle CR. Ding H, et al. Pflugers Arch. 2010 May;459(6):977-94. doi: 10.1007/s00424-010-0807-3. Epub 2010 Mar 18. Pflugers Arch. 2010. PMID: 20238124 Review.

2

A review of endothelial dysfunction in diabetes: a focus on the contribution of a dysfunctional eNOS.

Triggle CR, Ding H. Triggle CR, et al. Among authors: ding h. J Am Soc Hypertens. 2010 May-Jun;4(3):102-15. doi: 10.1016/j.jash.2010.02.004. J Am Soc Hypertens. 2010. PMID: 20470995 Review.

3

The endothelium in compliance and resistance vessels.

Triggle CR, Ding H. Triggle CR, et al. Among authors: ding h. Front Biosci (Schol Ed). 2011 Jan 1;3(2):730-44. doi: 10.2741/s183. Front Biosci (Schol Ed). 2011. PMID: 21196408 Free article. Review.

4

Endothelial dysfunction in diabetes mellitus: possible involvement of endoplasmic reticulum stress?

Basha B, Samuel SM, Triggle CR, Ding H. Basha B, et al. Among authors: ding h. Exp Diabetes Res. 2012;2012:481840. doi: 10.1155/2012/481840. Epub 2012 Feb 28. Exp Diabetes Res. 2012. PMID: 22474423 Free PMC article. Review.

5

The endothelium: influencing vascular smooth muscle in many ways.

Triggle CR, Samuel SM, Ravishankar S, Marei I, Arunachalam G, Ding H. Triggle CR, et al. Among authors: ding h. Can J Physiol Pharmacol. 2012 Jun;90(6):713-38. doi: 10.1139/y2012-073. Epub 2012 May 24. Can J Physiol Pharmacol. 2012. PMID: 22625870 Free article. Review.

6

Metformin modulates hyperglycaemia-induced endothelial senescence and apoptosis through SIRT1.

Arunachalam G, Samuel SM, Marei I, Ding H, Triggle CR. Arunachalam G, et al. Among authors: ding h. Br J Pharmacol. 2014 Jan;171(2):523-35. doi: 10.1111/bph.12496. Br J Pharmacol. 2014. PMID: 24372553 Free PMC article.

7

Metformin improves endothelial function in aortic tissue and microvascular endothelial cells subjected to diabetic hyperglycaemic conditions.

Ghosh S, Lakshmanan AP, Hwang MJ, Kubba H, Mushannen A, Triggle CR, Ding H. Ghosh S, et al. Among authors: ding h. Biochem Pharmacol. 2015 Dec 1;98(3):412-21. doi: 10.1016/j.bcp.2015.10.008. Epub 2015 Oct 20. Biochem Pharmacol. 2015. PMID: 26467186

8

Hyperglycaemic impairment of PAR2-mediated vasodilation: Prevention by inhibition of aortic endothelial sodium-glucose-co-Transporter-2 and minimizing oxidative stress.

El-Daly M, Pulakazhi Venu VK, Saifeddine M, Mihara K, Kang S, Fedak PWM, Alston LA, Hirota SA, Ding H, Triggle CR, Hollenberg MD. El-Daly M, et al. Among authors: ding h. Vascul Pharmacol. 2018 Oct;109:56-71. doi: 10.1016/j.vph.2018.06.006. Epub 2018 Jun 13. Vascul Pharmacol. 2018. PMID: 29908295

9

Impact of currently used anti-diabetic drugs on myoendothelial communication.

Ding H, Ye K, Triggle CR. Ding H, et al. Curr Opin Pharmacol. 2019 Apr;45:1-7. doi: 10.1016/j.coph.2018.11.002. Epub 2018 Nov 28. Curr Opin Pharmacol. 2019. PMID: 30502742 Review.

10

Minimizing Hyperglycemia-Induced Vascular Endothelial Dysfunction by Inhibiting Endothelial Sodium-Glucose Cotransporter 2 and Attenuating Oxidative Stress: Implications for Treating Individuals With Type 2 Diabetes.

Pulakazhi Venu VK, El-Daly M, Saifeddine M, Hirota SA, Ding H, Triggle CR, Hollenberg MD. Pulakazhi Venu VK, et al. Among authors: ding h. Can J Diabetes. 2019 Oct;43(7):510-514. doi: 10.1016/j.jcjd.2019.01.005. Epub 2019 Jan 23. Can J Diabetes. 2019. PMID: 30930073

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,905 results

Search Page